Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,280,678
+$155,991 QoQ
Shares Held
24,730
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.97%
of 13F equity value
Holder Rank
#1,452
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cohen Investment Advisors LLC holds $29,370,058 across 10 Drug Manufacturers - General names. JNJ ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,242 | $12,284,562 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
24,730 | $6,280,678 | |
| 3 | AMGN |
Amgen Inc
|
12,195 | $4,416,052 | |
| 4 | PFE |
Pfizer Inc
|
124,325 | $2,993,745 | |
| 5 | AZN |
Astrazeneca PLC
|
3,602 | $683,011 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,231 | $672,183 | |
| 7 | NVS |
Novartis AG
|
3,555 | $557,139 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,581 | $552,057 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,280,678 | 24,730 | Shares | Other | 2026-07-27 | |
| 2026-03-31 | $6,124,687 | 25,056 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $5,224,866 | 25,247 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $4,640,877 | 25,029 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $3,683,871 | 24,117 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,598,562 | 21,699 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,824,428 | 19,530 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,085,622 | 19,040 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,919,080 | 13,130 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,082,015 | 19,483 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,775,865 | 17,710 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,044,997 | 13,130 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,600,153 | 15,709 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $2,612,990 | 16,858 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,954,471 | 16,725 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $2,696,583 | 16,507 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $2,957,316 | 16,660 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $2,949,107 | 16,640 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,848,486 | 16,651 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,656,998 | 16,452 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,719,857 | 16,510 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,828,792 | 17,212 | Shares | Sole | 2021-08-05 | |
| 2020-12-31 | $2,572,218 | 16,344 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||